Stocks and Investing Stocks and Investing
Wed, April 17, 2024

Colin Bristow Maintained (VRTX) at Strong Buy with Decreased Target to $466 on, Apr 17th, 2024


Published on 2024-10-28 10:25:27 - WOPRAI, Colin Bristow
  Print publication without navigation


Colin Bristow of UBS, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Decreased Target from $498 to $466 on, Apr 17th, 2024.

Colin has made no other calls on VRTX in the last 4 months.



There are 14 other peers that have a rating on VRTX. Out of the 14 peers that are also analyzing VRTX, 3 agree with Colin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Increased Target to $420 on, Tuesday, February 6th, 2024
  • William Pickering of "Bernstein" Downgraded from Buy to Hold on, Friday, February 2nd, 2024
  • Naz Rahman of "Maxim Group" Downgraded from Strong Buy to Hold on, Wednesday, January 31st, 2024


These are the ratings of the 11 analyists that currently disagree with Colin


  • Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $500 on, Monday, April 15th, 2024
  • Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell and Held Target at $371 on, Friday, April 12th, 2024
  • Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $438 on, Thursday, April 11th, 2024
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $462 on, Thursday, April 11th, 2024
  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $440 on, Tuesday, February 20th, 2024
  • Andy Chen of "Wolfe Research" Initiated at Buy on, Thursday, February 15th, 2024
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $472 on, Tuesday, February 6th, 2024
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $540 on, Tuesday, February 6th, 2024
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $450 on, Tuesday, February 6th, 2024
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $508 on, Wednesday, January 31st, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $559 on, Wednesday, January 31st, 2024
Contributing Sources